LIANBIO-ADR (LIAN)

US53000N1081 - ADR

0.319  -0.03 (-8.28%)

After market: 0.32 +0 (+0.31%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-9-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
106.56M125.35M195.57M134.87M24.34M
Research and Development
39.88M59.76M158.69M120.89M22.62M
Selling, General, and Administrative Expenses
66.68M65.60M36.88M13.98M1.71M
Operating Income
-106.56M-125.35M-195.57M-134.87M-24.34M
Interest Income/Expense
9.95M4.32M240.00K-4.85M10.00K
Other Income/Expense
9.51M10.41M-460.00K120.00K0.00
Income Before Taxes
-87.11M-110.62M-195.78M-139.60M-24.33M
Income Tax
880.00K-330.00K520.00K0.000.00
Net Income
-87.99M-110.29M-196.30M-139.60M-24.33M
EBITDA
-105.26M-124.34M-195.04M-134.79MN/A
 
Per Share Data
EPS Diluted Total Ops
-0.81-1.02-1.86-1.33-0.23
Non GAAP EPS
-0.81-1.02N/AN/AN/A
 
Statistics

All data in USD

Charts